Noema Pharma adds Darren Carroll and Arthur Franken to Board along with raising CHF54m Series A financing co-led by Sofinnova Partners and Polaris Partners

– SWITZERLAND, Basel –  Noema Pharma AG, a Swiss clinical-stage company targeting orphan neurological disorders, today announced it has successfully concluded an oversubscribed Series A CHF54 million financing round co-led by Sofinnova Partners and Polaris Partners alongside a global consortium of new international investors includes Gilde Healthcare, Invus, and BioMed Partners.…

ByHeart adds Amy Schulman and Hemi Zucker to Board along with raising $70m Series A financing led by Polaris Partners, OCV Partners and D1 Capital Partners

– USA, NY –  ByHeart, a company focused on the evolution of one of our most fundamental nutrition markets – infant & baby – today announced the recent closing of $70 million in Series A funding led by Polaris Partners, D1 Capital Partners, and OCV Partners, in advance of its first infant formula product launch in 2021.…

Cardurion Pharmaceuticals announces Amy Schulman to its Board along with a private investment from Polaris Partners

– USA, MA –  Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in biotechnology.…